7*24

Hot topic

Market

Activities

The conflict in the Middle East has disrupted the normal flow of oil, leading to a squeeze in supply for cooking and transportation purposes. Countries in the subcontinent, especially India, are facin

BRICS Proposes Joint Food Reserves To Combat Middle East Crisis

WL: Ethereum L2/Sidechain

Taiwan-based clinical-stage biopharmaceutical company Senhwa Biosciences is strengthening its push into artificial intelligence-powered drug discovery after securing up to $16 million in funding from 

Taiwan-based clinical-stage biopharmaceutical company Senhwa Biosciences is strengthening its push into artificial intelligence-powered drug discovery after securing up to $16 million in funding from GEM Yield Bahamas Limited, an affiliate of Global Emerging Markets.
The partnership is designed to accelerate Senhwa’s clinical pipeline, expand its oncology programs, and scale its AI and machine learning-based drug discovery platform.
AI Meets Oncology Innovation
Senhwa has been increasingly focused on integrating AI into the drug development process, particularly in cancer research. The company is working on advanced computational methods to analyze complex biological data and identify more effective treatment combinations for various cancers.
A key part of this effort involves its collaboration with biotech firm CellType, using a “cell-to-sentence” approach that translates complex cellular data into structured formats that can be processed by machine learning systems. This allows researchers to extract insights faster and more efficiently than traditional methods.
Advancing Immuno-Oncology Strategies
One of Senhwa’s core research directions is its “cold-to-hot tumor” strategy. In cancer immunotherapy:
“Cold” tumors are less responsive to immune system attacks
“Hot” tumors are more active and responsive to treatment
By leveraging AI-driven analysis and drug discovery, Senhwa aims to enhance immune system activation within tumor environments, potentially improving treatment effectiveness in hard-to-treat cancers.
Early validation results suggest that its lead compounds may help modulate immune responses within tumor microenvironments, supporting its approach within the emerging immuno-oncology 2.0 field.
Faster Drug Discovery Through AI
AI-assisted drug development is increasingly becoming a standard in modern biopharma research. It enables:


Senhwa Biosciences Expands AI-Driven Drug Developm

On April 14, Fortune magazine reported that American Express announced on Tuesday the launch of a developer toolkit aimed at agent-based commerce, while also providing purchase protection for erroneou

American Express Launches Tools for AI Payment Development

edgeX: Sub-10ms Global DeFi Layer

Algorand: Can ALGO target $0.1271 after a 10% price breakout? Algorand [ALGO] has staged a strong comeback over the last 24 hours, posting a 10% gain at press time, a move many traders had anticipated

Algorand: Can ALGO target $0.1271 after a 10% price breakout?

Algorand [ALGO] has staged a strong comeback over the last 24 hours, posting a 10% gain at press time, a move many traders had anticipated. Price entered the imbalance zone, filled it cleanly, and then reversed with intent.

That type of reaction rarely occurs by chance; it typically indicates that the market has discovered short-term value. Moreover, the price rebound gained momentum, suggesting that buyers were ready to step in once the imbalance was cleared.

Algorand: Can ALGO target $0.1271 after a 10% pric

Vote to help HTX win & share 300 USDT!

the recent announcement by the Central Bank of Russia regarding mandatory real-name systems for crypto transactions has introduced significant implications for market dynamics. As we explore the tradi

Daily BTC Guess: Win 18M HTX!HTX Community Spring Creation ContestClaim1,200 USDT in the Monthly Creation Challenge'Sports is the entry point, not the endgame': Bernstein projects prediction market se

Claim1,200 USDT in the Monthly Creation Challenge

'Sports is the entry point, not the endgame': Bernstein projects prediction market sector to reach $1 trillion in annual volume by 2030
Analysts at Bernstein expect prediction market volumes to scale from around $51 billion in 2025 to $1 trillion by 2030, driven by regulatory clarity and mainstream distribution partnerships.

The analysts see “asymmetric upside” for Robinhood from prediction market growth, setting a $130 price target for the stock.
As prediction markets evolve into broader information markets across sports, economics, politics, and culture, analysts at research and brokerage firm Bernstein have projected the sector to reach $1 trillion in annual volume by 2030, citing regulatory clarity, mainstream distribution partnerships, and a structural liquidity edge over traditional gaming markets.

Prediction markets generated around $51 billion in volume during 2025, the analysts led by Gautam Chhugani highlighted in a Tuesday note to clients, tripling year over year as liquidity rotated from the 2024 U.S. election cycle toward sports, crypto, macro, and political contracts.

"Increasing regulatory clarity at the federal level (vs. state-regulated traditional frameworks) is expanding the addressable market, while blockchain-based tokenization and integration with crypto markets is enabling global liquidity, long-tail event creation and participation from institutions," the analysts said.

Despite state-level scrutiny in recent months, particularly surrounding sports event contracts, the CFTC has asserted that it holds "exclusive jurisdiction" over prediction markets and is seeking to write rules as the industry expands. 

Kalshi and Polymarket have already executed a combined $60 billion in volume so far this year, with the analysts expecting $240 billion in 2026 and an 80% compound annual growth rate through the end of 2030.





'Sports is the entry point, not the endgame':

reflecting a healthy increase of approximately 3.34%. The movement between the high and low prices denotes a volatile trading session, which is common in the cryptocurrency market, especially when inf

BASED: Hyperliquid’s On-Chain Super App

A final shakeout phase before a potential breakout is playing out for XRP, according to market analyst Gain Muse. XRP's consolidation inside a long-term wedge has gone through the roof, illustrating t

A final shakeout phase before a potential breakout is playing out for XRP, according to market analyst Gain Muse. XRP's consolidation inside a long-term wedge has gone through the roof, illustrating tightening volatility as a macro trend continues to mature. Therefore, beneath the surface, XRP's compression might be reaching a boiling point, with the current liquidity trap favoring long-term, larger players at the expense of weaker ones, as accumulation is occurring at discounted levels.GainMuse acknowledges that $1.28-$1.29 is the key support area, with XRP's current price slightly above this zone at $1.33 per, according to CoinGecko data. Market sentiment and on-chain indicators add further intrigue, given that XRP's fear, uncertainty, and doubt (FUD) has jumped to elevated levels.Interestingly, this bearish sentiment usually aligns with local bottoms rather than breakdowns, suggesting that XRP might be in for an upward reversal. For now, the convergence of heightened pessimism, declining exchange supply, and technical compression may be a telling sign that a meteoric liftoff is in the picture for XRP.With the $1.28-$1.29 zone being a vital inflection point that could trigger a broader recovery phase or extend the current corrective structure, GainMuse acknowledges that the next macro resistance ceiling sits at the $1.41-$1.42 area.

A final shakeout phase before a potential breakout

HTX Community Spring Creation ContestUnlock Your Personal HTX Airdrop NowVote to help HTX win & share 300 USDT!Scaramucci says SpaceX is a proof companies now view Bitcoin as a strategic reserve a Spa

Scaramucci says SpaceX is a proof companies now view Bitcoin as a strategic reserve a

SpaceX is holding onto 8,285 bitcoins valued at $603 million even as the company reported a nearly $5 billion loss for 2025, new data shows.

The aerospace firm keeps its digital currency in Coinbase Prime custody and has not sold any despite the financial hit, according to the data from Arkham Intelligence and The Information report published Friday. The loss is a complete turnaround from the previous year when SpaceX made about $8 billion in profit on sales between $15 billion and $16 billion.

The company’s bitcoin balance stayed steady since the middle of 2024 after hitting a peak value above $1.6 billion during October 2025 when bitcoin reached record highs. SpaceX now ranks as the fourth-biggest known corporate bitcoin owner, trailing only Strategy, Marathon Digital, and Riot Platforms.

SpaceX filed for an initial public offering last month that will require the company to reveal its bitcoin holdings in public documents for the first time. This could force the company to make accounting choices under new FASB rules that started in late 2025.

SkyBridge Capital founder Anthony Scaramucci said the mov e shows how companies will treat bitcoin going forward. “Everyone will soon have Bitcoin on their corporate balance sheet,” he said, calling SpaceX the ultimate example of keeping bitcoin as a company reserve asset.

Scaramucci says SpaceX is a proof companies now vi

People think I’m crazy... But I don’t care. 🧠🔥 I will continue to buy $SOL until I reach 10,000 coins. Now I have 6,600 $SOL... Only 3,400 left. If $SOL reaches $10,000... That would be $100,000,000. 

WAR: Geopolitical Meme Coin on Solana

nice

Article

X Platform Product Head: Cryptocurrency Has Had a Tough Year; Perhaps We Should Launch Something to Fix It

Pakistan Calls for 45-Day Extension of US-Iran Ceasefire

Pakistan Reports US-Iran Agree to Continue Negotiations, Time and Place Undecided

nice

Todos los comentarios0Lo más recientePopular

Temas populares